{
    "id": 23875,
    "fullName": "SS18 - SSX2",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "SS18-SSX2 results from the fusion of SS18 and SSX2, and leads to altered DNA methylation and gene expression and promotes tumor formation (PMID: 17018603, PMID: 26259251, PMID: 26571495). SS18-SSX2 is associated with synovial sarcoma (PMID: 17018603, PMID: 26259251, PMID: 26571495).",
            "references": [
                {
                    "id": 10264,
                    "pubMedId": 26571495,
                    "title": "SS18-SSX, the Oncogenic Fusion Protein in Synovial Sarcoma, Is a Cellular Context-Dependent Epigenetic Modifier.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26571495"
                },
                {
                    "id": 10266,
                    "pubMedId": 17018603,
                    "title": "The synovial-sarcoma-associated SS18-SSX2 fusion protein induces epigenetic gene (de)regulation.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/17018603"
                },
                {
                    "id": 10265,
                    "pubMedId": 26259251,
                    "title": "\u03b2-catenin stabilization enhances SS18-SSX2-driven synovial sarcomagenesis and blocks the mesenchymal to epithelial transition.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26259251"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 6760,
        "geneSymbol": "SS18",
        "terms": [
            "SS18",
            "SSXT",
            "SYT"
        ]
    },
    "variant": "SS18 - SSX2",
    "createDate": "06/28/2016",
    "updateDate": "11/08/2017",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 6757,
                "geneSymbol": "SSX2",
                "terms": [
                    "SSX2",
                    "CT5.2",
                    "CT5.2A",
                    "HD21",
                    "HOM-MEL-40",
                    "SSX"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 7225,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CGP049090 induced apoptosis and inhibited growth of several synovial sarcoma cell lines harboring SS18 - SSX2 fusion in culture, and inhibited tumor growth in one synovial sarcoma cell line xenograft model (PMID: 24166495).",
            "molecularProfile": {
                "id": 24600,
                "profileName": "SS18 - SSX2"
            },
            "therapy": {
                "id": 2082,
                "therapyName": "CGP049090",
                "synonyms": null
            },
            "indication": {
                "id": 5485,
                "name": "synovial sarcoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6226,
                    "pubMedId": 24166495,
                    "title": "SS18-SSX fusion protein-induced Wnt/\u03b2-catenin signaling is a therapeutic target in synovial sarcoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24166495"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 12941,
            "approvalStatus": "Guideline",
            "evidenceType": "Diagnostic",
            "efficacyEvidence": "SS18-SSX2 fusions aid the diagnosis of synovial sarcoma (NCCN.org).",
            "molecularProfile": {
                "id": 24600,
                "profileName": "SS18 - SSX2"
            },
            "therapy": {
                "id": 1776,
                "therapyName": "N/A",
                "synonyms": null
            },
            "indication": {
                "id": 5485,
                "name": "synovial sarcoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 10889,
                    "pubMedId": null,
                    "title": "NCCN.org",
                    "url": "https://www.nccn.org/professionals/physician_gls/default.aspx"
                }
            ],
            "ampCapAscoEvidenceLevel": "A",
            "ampCapAscoInferredTier": "I"
        },
        {
            "id": 7223,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, PKF115-584 induced apoptosis and inhibited growth of synovial sarcoma cell lines harboring SS18 - SSX2 fusion in culture (PMID: 24166495).",
            "molecularProfile": {
                "id": 24600,
                "profileName": "SS18 - SSX2"
            },
            "therapy": {
                "id": 2081,
                "therapyName": "PKF115-584",
                "synonyms": null
            },
            "indication": {
                "id": 5485,
                "name": "synovial sarcoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6226,
                    "pubMedId": 24166495,
                    "title": "SS18-SSX fusion protein-induced Wnt/\u03b2-catenin signaling is a therapeutic target in synovial sarcoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24166495"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 7224,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, PKF118-310 induced apoptosis and inhibited growth of synovial sarcoma cell lines harboring SS18 - SSX2 fusion in culture (PMID: 24166495).",
            "molecularProfile": {
                "id": 24600,
                "profileName": "SS18 - SSX2"
            },
            "therapy": {
                "id": 2397,
                "therapyName": "PKF118-310",
                "synonyms": null
            },
            "indication": {
                "id": 5485,
                "name": "synovial sarcoma",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6226,
                    "pubMedId": 24166495,
                    "title": "SS18-SSX fusion protein-induced Wnt/\u03b2-catenin signaling is a therapeutic target in synovial sarcoma.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/24166495"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24600,
            "profileName": "SS18 - SSX2",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}